Skip to content

Clinical trials

Rhabdomyosarcoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rhabdomyosarcoma Clear all

229 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20013
20024
20036
20045
20052
20068
20078
20086
20095
20108
20118
20128
201310
20147
20159
201610
201714
201811
20196
202010
202113
20227
20235
20249
202512
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed114
Recruiting37
Active, not recruiting27
Terminated18
Unknown status12
Withdrawn10
Not yet recruiting8
Suspended1
No longer available1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)39
St. Jude Children's Research Hospital17
Children's Oncology Group15
European Organisation for Research and Treatment of Cancer - EORTC11
Baylor College of Medicine7
Memorial Sloan Kettering Cancer Center6
Emory University5
Eli Lilly and Company4
Seattle Children's Hospital4
Children's National Research Institute3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rhabdomyosarcoma229
Sarcoma124
Sarcoma, Ewing106
Osteosarcoma93
Neuroblastoma91
Wilms Tumor59
Medulloblastoma40
Rhabdoid Tumor40
Sarcoma, Synovial38
Neuroectodermal Tumors, Primitive, Peripheral36

Trials

Showing 26 to 50 of 229. Each trial links to its page on Pharma Observatory.

129 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.